FdaApplication
NDA 010418
Identifiers
- fda_app_no: NDA010418
Properties
| Property | Value |
|---|---|
| applicant_name | ASTRAZENECA LP |
| application_type | NDA |
Products (6)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| XYLOCAINE | LIDOCAINE HYDROCHLORIDE | 2% | INJECTABLE;INJECTION |
| XYLOCAINE | LIDOCAINE HYDROCHLORIDE | 1.5% | INJECTABLE;INJECTION |
| XYLOCAINE | LIDOCAINE HYDROCHLORIDE | 1% | INJECTABLE;INJECTION |
| XYLOCAINE W/ EPINEPHRINE | EPINEPHRINE; LIDOCAINE HYDROCHLORIDE | 0.005MG/ML;1.5% | INJECTABLE;INJECTION |
| XYLOCAINE W/ EPINEPHRINE | EPINEPHRINE; LIDOCAINE HYDROCHLORIDE | 0.005MG/ML;2% | INJECTABLE;INJECTION |
| XYLOCAINE W/ EPINEPHRINE | EPINEPHRINE; LIDOCAINE HYDROCHLORIDE | 0.005MG/ML;1% | INJECTABLE;INJECTION |
6 products